MiRNA-26b regulates the expression of cyclooxygenase-2 in desferrioxamine-treated CNE cells

FEBS Lett. 2010 Mar 5;584(5):961-7. doi: 10.1016/j.febslet.2010.01.036. Epub 2010 Jan 26.

Abstract

Here we report that miR-26b is involved in COX-2 overexpression in desferrioxamine (DFOM)-treated carcinoma of nasopharyngeal epithelial (CNE) cells. The level of miR-26b in DFOM-treated CNE cells is inversely proportional to the expression level of the COX-2 protein. Overexpression of miR-26b in DFOM-treated CNE cells inhibits cell proliferation. A luciferase reporter gene experiment suggests that the 3' untranslated region of COX-2 carries a binding site for miR-26b. Overexpression of miR-26b marginally reduces the levels of COX-2 protein in DFOM-treated CNE cells. Moreover, knockdown of COX-2 expression had a similar effect to overexpression of miR-26b. Taken together, these results suggest that miR-26b regulates COX-2 expression in DFOM-treated cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • Cell Line
  • Cell Line, Tumor
  • Cell Proliferation
  • Computational Biology
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism*
  • Deferoxamine / pharmacology
  • Gene Expression Regulation, Neoplastic* / drug effects
  • Gene Expression Regulation, Neoplastic* / genetics
  • Humans
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Polymerase Chain Reaction
  • Siderophores / pharmacology

Substances

  • MicroRNAs
  • Siderophores
  • Cyclooxygenase 2
  • Deferoxamine